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α-Synuclein is a highly-conserved 140 amino-acid neu-
ronal protein expressed in numerous areas throughout the brain
[1-5] and enriched in presynaptic terminals [2,3,6,7]. A num-
ber of roles have been ascribed to α-synuclein in synaptic func-
tion, maintenance, and plasticity in the central nervous sys-
tem (CNS) [7-10]. High levels of this protein are found in
midbrain dopaminergic neurons [5,11,12], where it appears to
modulate nigrostriatal neurotransmission and tyrosine hy-
droxylase activity [13-15]. Mutations in the α-synuclein-en-
coding gene, SNCA (OMIM 163890), have been associated
with familial autosomal-dominant, juvenile forms of
Parkinson’s disease (PD), which are phenotypically equiva-
lent in their clinical symptoms to sporadic parkinsonism. α-
Synuclein is known to constitute the major fibrillar compo-
nent of Lewy bodies [16], i.e. the large intracytoplasmic in-
clusions typically observed within dopaminergic neurons of
idiopathic and familial PD patients. The colocalization of α-
synuclein and ubiquitin in these inclusions has led to the hy-
pothesis that conformational changes derived from mutation
or overexpression of the α-synuclein gene hamper its degra-
dation by the ubiquitin-proteasome system, with ensuing cy-
tosolic accumulation, aggregation and fibrillogenesis
[10,15,17,18]. Accumulation of wild-type α-synuclein has also
been found with synaptic loss in the substantia nigra of mon-
key models of PD treated with the neurotoxic 1-methyl-4-phe-
nyl-1,2,3,6-tetrahydropyridine (MPTP), which selectively kills
dopaminergic cells of the brain and the retina [19,20]. α-
Synuclein deposits have also been reported in patients with
other neurodegenerative disorders involving Lewy body for-
mation, collectively known as “synucleopathies”, including
dementia with Lewy bodies, multiple system atrophy, amyo-
trophic lateral sclerosis, and some Alzheimer’s disease vari-
ants [7,8,10,21,22]. Furthermore, transgenic overexpression
of human wild-type or mutant α-synuclein variants in the
mouse brain leads to loss of dopaminergic neurons and de-
crease of tyrosine hydroxylase levels, correlating with the for-
mation of Lewy body-like intraneuronal inclusions and the
development of motor deficits [23-26].
Apart from studies in the brain, the expression and distri-
bution of α-synuclein in the normal retina of vertebrates has
not been studied in depth. Given the growing body of experi-
mental evidence concerning visual dysfunction and morpho-
logical impairments in the retina of PD patients and MPTP-
treated animals [27-30], including that from our group [20],
we set out to analyze α-synuclein expression at the mRNA
and protein levels and to characterize its distribution pattern
in the distinct retinal layers and cell types. This study involved
©2007 Molecular Vision
α α α α α-Synuclein gene expression profile in the retina of vertebrates
Gema C. Martínez-Navarrete,1 José Martín-Nieto,1 Julián Esteve-Rudd,1 Antonia Angulo,2 Nicolás Cuenca1
1Departamento de Fisiología, Genética y Microbiología, Facultad de Ciencias, Universidad de Alicante, Alicante, 2Departamento
de Optica, Farmacología y Anatomía, Escuela Universitaria de Optica y Optometría, Universidad de Alicante, Alicante, Spain
Purpose: α-Synuclein is a Parkinson’s disease-linked protein of ubiquitous expression in the central nervous system. It
has a proposed role in the modulation of neurotransmission and synaptic function. This study was aimed at analyzing
expression of the α-synuclein gene in the normal retina, and characterizing its pattern of distribution in the different retinal
cell types and layers in a variety of vertebrates, ranging from fish to humans.
Methods: Reverse transcriptase-polymerase chain reaction and immunoblotting were used to assess α-synuclein expres-
sion at both mRNA and protein levels. Its retinal distribution profile was characterized by immunohistochemical methods.
With this purpose, retinal sections were analyzed under fluorescent confocal microscopy using specific antibodies against
α-synuclein, alone and in double or triple combinations with a set of antibodies to molecular markers for the distinct
retinal neuronal types. Also, synaptophysin was used as a marker for synaptic vesicles in the retina.
Results: α-Synuclein mRNA and protein were expressed by both retinal pigment epithelium (RPE) and neural retinal
cells. The pattern of α-synuclein distribution in the retina was quite consistent across all vertebrate species examined. A
strong immunoreactivity was found in the outer segments (OS) of photoreceptors and in their axon terminals (cone pedicles
and rod spherules) in the outer plexiform layer (OPL) of the retina. α-Synuclein was also present in rod and cone bipolar
cells, as well as in GABAergic and glycinergic amacrines, distributing along a complex plexus throughout the inner
plexiform layer (IPL). Additionally, colocalization was found between α-synuclein and synaptophysin at presynaptic
terminals of the retina. α-Synuclein-positive phagosome-like structures were observed in the cytoplasm of RPE cells.
Conclusions: An involvement of α-synuclein can be postulated in neurotransmission at axon terminals of photoreceptors
in the OPL, and at presynaptic endings of bipolar and amacrine cells in the IPL. As well, this protein could have a role in
the function as well as the maintenance of photoreceptor OS. α-Synuclein contained in RPE cells should derive not only
from protein expression by this cell type, but also from their phagocytosis of OS disc membranes.
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949a wide spectrum of vertebrates, including both non-mamma-
lian and mammalian species ranging from fish to humans, and
was designed to obtain clues to the physiological role of α-
synuclein in the retina.
METHODS
Biological material:  The following non-mammalian verte-
brate species were studied in this work: carp (Cyprinus carpio),
African clawed toad (Xenopus laevis), yellow-bellied slider
turtle (Trachemys scripta scripta), and chicken (Gallus gallus
domesticus). The following mammalian species were studied:
mouse (Mus musculus, C56BL/6J unless otherwise stated),
rat (Rattus norvegicus, Wistar), cat (Felis catus), California
ground squirrel (Spermophilus beecheyi), European wild rab-
bit (Oryctolagus cuniculus), Iberian pig (Sus scrofa
mediterraneus), cow (Bos taurus), cynomolgus monkey
(Macaca fascicularis), and human (Homo sapiens). Carps and
turtles were purchased from local petshops. Xenopus, rodents,
and cats were kept at our university animal-care facilities.
Monkeys (five to six years old) were kept at the Universidad
de Murcia in accordance with the International Primate Soci-
ety guidelines. They were maintained in a special room with
controlled temperature (22-24 °C), a 12 h light and dark cycle,
humidity at 40-60% and suitable ventilation [31]. They were
given fresh fruit and special food for primates (Old World Pri-
mate Diet Expanded) from B & K Universal (Hull, UK), and
provided with water ad libitum. No individual was killed solely
for the purpose of the research reported here, but instead other
body parts were harvested by different researchers for a range
of unrelated experiments.
All animal handling was carried out in compliance with
the guidelines set by the National Institutes of Health and the
European Directive 86/609/EEC. Animals were euthanized
according to standard, internationally-approved protocols, and
their eyes were immediately enucleated afterwards. Fresh
chicken, rabbit, porcine, and bovine eyes were provided by
local farms or slaughterhouses. Paraformaldehyde-fixed squir-
rel eyes were obtained from the University of California (Santa
Barbara, CA). Post-mortem human eyes from donors in the
45-60 year-old range were obtained from the Utah Lions Eye
Bank (Salt Lake City, UT). For RNA and protein extraction,
dissected retinal fractions were snap-frozen in liquid nitrogen
and immediately stored at -80 °C without fixation. For immu-
nohistochemistry, eyes were fixed in 4% paraformaldehyde
in 0.1 M sodium phosphate buffer pH 7.4 for 1 h, and then
subjected to sucrose cryoprotection [32] before storage at -80
°C.
Reverse transcriptase-polymerase chain reaction:  RNA
was extracted from the neural retina and retinal pigment epi-
thelium (RPE) fractions using the RNAqueous-4PCR Kit from
Ambion (Austin, TX), and then treated with DNAse I follow-
ing the manufacturers’ instructions. RNA from human retina
was purchased from Clontech BD (Mountain View, CA). Re-
verse transcription into cDNA was carried out using the
RETROscript Kit (Ambion), at 44 °C for 1 h in 20 µl of a
reaction mixture containing 0.5-1.0 µg of RNA, the four dNTPs
at 0.5 mM each, 5 µM oligo(dT) or random decamers, 10 U of
RNase inhibitor and 100 U of MMLV reverse transcriptase.
PCR amplification was carried out from 10 ng of cDNA in 50
µl of a reaction mixture containing forward and reverse prim-
ers at 0.25 µM each, the four dNTPs at 125 µM each, and 1 U
of  Taq  DNA polymerase (Amersham Biosciences,
Buckinghamshire, UK). Using the Primer3 software [33], we
designed PCR primers to bear a Tm of 60 °C, flank at least one
intron, and have 100% identity with their corresponding cDNA
sequences. The primers were as follows: for human and mon-
key α-synuclein (Genbank NM_000345 and AH013262, re-
spectively), forward: 5'-AAA ACC AAG GAG GGA GTG GT-
3' (exon 3), reverse: 5'-TCA AGA AAC TGG GAG CAA AGA-
3' (exon 6); for bovine α-synuclein (Genbank
NM_001034041), forward: 5'-GTG GTG ACA GGG GTG
ACT G-3' (exon 4), reverse: 5'-CTT CGG GTT CGT AGT
CCT GA-3' (exon 6); for mouse and rat α-synuclein (Genbank
NM_009221 and NM_019169, respectively), forward: 5'-GCA
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TABLE 1. PRIMARY ANTIBODIES USED FOR IMMUNOHISTOCHEMISTRY
                                                                                                                Working
           Molecular marker                   Antibody                              Source                      dilution
---------------------------------------   -------------------   ---------------------------------------------   --------
α-Synuclein                               Goat polyclonal       Santa Cruz Biotechnology (Santa Cruz, CA),       1:100
                                                                sc-7011
Calbindin D-28K                           Mouse, clone CB-955   Sigma Chemical, C9848                            1:500
GABA                                      Rat polyclonal        D.V. Pow, University of Queensland (Brisbane,    1:300
                                                                Australia)
Glycine                                   Rat polyclonal        D.V. Pow                                         1:300
Microtubule-associated protein-2 (MAP2)   Rabbit polyclonal     Chemicon, AB5622                                 1:500
Protein kinase C (PKC), α isoform         Mouse, clone MC5      Santa Cruz Biotechnology, sc-80                  1:100
Recoverin                                 Rabbit polyclonal     J.F. McGinnis, University of Oklahoma            1:5000
                                                                (Oklahoma City, OK)
Rhodopsin                                 Mouse, clone 4D2      R.S. Molday, University of British Columbia      1:100
                                                                (Vancouver, Canada)
S-cone opsin                              Mouse, clone JH455    J. Nathans, Johns Hopkins School of Medicine     1:500
                                                                (Baltimore, MD)
Synaptophysin                             Mouse, clone SY38     Chemicon, MAB5258                                1:500
Transducin, Gγ c subunit                  Rabbit polyclonal     Cytosignal (Irvine, CA), PAB-00801-G             1:500
Recorded are the primary antibodies used in this study. The antibody column lists antigen and animal origin. The clone designation is given for
monoclonal antibodies. The source column provides either the commercial company and antibody reference, or the investigator and affilia-
tion. The last column specifies the dilution at which each antibody was used on retinal sections.
950GTG GTG ACT GGT GTG AC-3' (exon 4), reverse, 5'-CGA
TCA CTG CTG ATG GAA GA-3' (exon 6). After an initial
denaturation step at 95 °C for 5 min, amplification was per-
formed for a total of 30 cycles each at 60 °C for 1 min, 72 °C
for 2 min, and 95 °C for 1 min, and concluded with a final
annealing at 60 °C for 1 min and elongation at 72 °C for 5
min. PCR products were run on 2% agarose gels stained with
SYBR Green I (Sigma Chemical, St. Louis, MO) and verified
by automated DNA sequencing.
Immunoblotting:  Retinal proteins were extracted follow-
ing guidelines described in reference [34]. Briefly, cells were
lysed for 15-20 min on ice in two volumes of a buffer com-
posed of 20 mM sodium Hepes pH 7.9, 10% glycerol, 10 mM
KCl, 0.4 M NaCl, 1% Nonidet P-40, 2 mM DTT and protease
inhibitors (1 mM PMSF, 10 µM leupeptin, 0.3 µM aprotinin,
and 100 µM benzamidine). The supernatants obtained after
centrifugation at 16,000xg for 10 min were used for
immunoblotting analysis. Proteins (50 µg/lane) were resolved
by SDS-PAGE on 5-20% polyacrylamide-gradient gels, and
after electrotransfer to PVDF membranes (Hybond-P,
Amersham) stained with SYPRO Ruby Protein Blot Stain
(Molecular Probes, Eugene, OR) to ensure even protein load-
ing and transfer. Membranes were then probed sequentially
with rabbit polyclonal antibody to α-synuclein (Chemicon
AB5038, Temecula, CA) at a 1:2000 dilution overnight and
horseradish peroxidase-conjugated anti-rabbit IgG antibody
at a 1:1000 dilution for 1 h. They were developed by means of
enhanced chemiluminescence (ECL) using the ECL plus West-
ern blotting detection system kit (Amersham). Images were
obtained upon exposure of Hyperfilm ECL plates to the blots.
Immunohistochemistry:  Cryostat vertical 16 µm retinal
sections were obtained and processed for immunohistochem-
istry based on guidelines established in references [20,32,35].
All primary antibodies used in this work (summarized in Table
1) have been utilized in several previous studies and are well
characterized by us and other authors regarding specific cell-
type immunostaining. Sections were subjected to single, double
or triple immunostaining overnight at room temperature with
antibodies against α-synuclein and a set of molecular markers
for the distinct retinal neuronal types, at the dilutions indi-
cated in Table 1 in 0.1 M sodium phosphate buffer pH 7.4
plus 0.5% Triton X-100. Thereafter, the corresponding sec-
ondary antibodies to IgG (Molecular Probes) conjugated to
Alexa Fluor 488 (green), 546 (red), or 647 (far red) were ap-
plied at a 1:100 dilution for 1 h. Control slides in which pri-
mary antibodies were omitted were processed in parallel, and
no immunoreactivity was found in any case. Fluorescence was
detected with a TCS SP2 confocal laser-scanning microscope
(Leica Microsystems, Wetzlar, Germany), using a pinhole di-
ameter of 77 µm. Images were obtained sequentially from the
green, red and/or far-red channels as optical slices with a thick-
ness <0.9 µm. Images from the far-red channel were
pseudocolored in blue.
RESULTS
 The retina from a number of mammalian species was dis-
sected into neural retina and RPE and used for RNA isolation.
As show in Figure 1A, both retinal tissues were found by RT-
PCR to contain the α-synuclein mRNA in all the species ana-
lyzed. At the protein level, α-synuclein expression was also
detected by immunoblotting in rodent (mouse and rat), bo-
vine, and primate neural retinas, where it migrated with an
(anomalous) apparent molecular mass of 19 kDa (Figure 1B),
consistent with previous reports [1,6]. Expression in the RPE
of the α-synuclein protein was also evidenced for the bovine,
monkey (Figure 1B) and mouse (data not shown) retinas.
The α-synuclein distribution profile in the retina was ex-
amined by means of immunofluorescent confocal microscopy
in a wide variety of vertebrate species. A fairly-consistent pat-
tern of α-synuclein retinal distribution was found across non-
mammalian vertebrates, including fish, amphibians, reptiles,
and birds, as illustrated in the low-magnification views of
immunostained retinal sections shown in Figure 2. In the carp,
photoreceptor cells were found to contain high levels of α-
synuclein in their outer segments (OS; Figure 2A). In addi-
tion, a strong immunoreactivity was observed in a certain sub-
type of amacrine cells (Figure 2A, arrowhead), whose fine
dendritic processes ramified in the inner plexiform layer (IPL).
Additionally, some ganglion cells showed a weaker α-
synuclein immunostaining. In Xenopus the strongest expres-
sion of this protein was found in the IPL (Figure 2B), although
immunoreactive cell bodies were also visible in the inner
nuclear layer (INL). Here horizontal cells (Figure 2B, arrows)
were identified by their location at the outermost part of the
INL, close to the outer plexiform layer (OPL), and their char-
acteristic thick horizontal processes, whereas α-synuclein-
positive rows of cells in the innermost part of the INL should
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Figure 1. Expression of the α-synuclein gene in the retina of mam-
mals.  Reverse transcriptase-polymerase chain reaction (A) and
immunoblotting analysis (B) of α-synuclein mRNA and protein ex-
pression, respectively, were carried out in the neural retina (R) and
retinal pigment epithelium (RPE) fractions from the indicated spe-
cies. Molecular sizes of bands obtained are given to the right of each
panel.
951correspond to amacrine cells. Neurons lying in between these
two cell types could be ascribed to bipolar cells. Similar to
fish, a number of ganglion cells in the toad displayed α-
synuclein immunoreactivity as well, although photoreceptors
were not labeled with antibodies to α-synuclein except in their
axon terminals in the OPL (Figure 2B, arrowheads). In the
turtle, two immunoreactive bands were evident in the outer
retina, one corresponding to the OS of photoreceptors and the
other to their synaptic endings in the OPL (Figure 2C). α-
Synuclein was also present in cell bodies residing in the in-
nermost rows of the INL, likely corresponding to bipolar and
amacrine cells. The IPL was also labeled for α-synuclein with
two bands of intense immunostaining observable in strata S2
and S4. Most cells in the ganglion cell layer also stained posi-
tive for this protein (Figure 2C). As with the turtle, two bands
of α-synuclein immunoreactivity in the chicken were detected
in the outermost neural retina, one corresponding to the pho-
toreceptor OS and the other to the OPL (Figure 2D). Addi-
tional α-synuclein expression was evident in the INL within
the somata of bipolar and amacrine cells. Two strongly-
immunopositive bands were visible in the IPL strata S2 and
S4. Finally, α-synuclein was found to be present as well in the
cell bodies and axons of some ganglion cells (Figure 2D).
The α-synuclein expression pattern was also analyzed by
immunohistochemistry in the retina of a number of mamma-
lian species ranging from rodents to humans. High levels of
α-synuclein were found in the photoreceptor OS layer of mam-
mals of nocturnal vision bearing rod-dominant retinas, such
as rodents. A faint immunoreactive band was also observed in
the OPL of mouse (Figure 3A) and rat (Figure 3B) retinas. α-
Synuclein was present as well in bipolar and amacrine cells,
and a homogeneous pattern of intense immunolabeling was
evident through the whole thickness of the IPL, without ob-
servable stratification. Weak immunoreactivity was addition-
ally seen in mouse and rat ganglion cells. In the cat retina, α-
synuclein labeling was observed in the OS of photoreceptors
and in their synaptic endings in the OPL (Figure 3C). As ob-
served in the mouse and rat, bipolar and amacrine cell bodies
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Figure 2. α-Synuclein immu-
noreactivity pattern in the
retina of non-mammalian ver-
tebrates.  Shown are retinal
sections from (A) carp, (B)
Xenopus, (C) turtle, and (D)
chicken immunolabeled for α-
synuclein. Arrows point to rod
outer segments in panel A and
to horizontal cells in panel B.
Arrowheads point to amacrine
cells in panel A and to photo-
receptor axon terminals in
panel B. The following abbre-
viations were used: outer
nuclear layer (ONL), ganglion
cell layer (GCL), inner nuclear
layer (INL), outer plexiform
layer (OPL), inner plexiform
layer (IPL), retinal pigment
epithelium (RPE), and outer
segments (OS). Each bars
equals 40 µm.
952of the cat retina were also immunostained whose dendrites
stratified at all sublevels (S1 through S5) of the IPL, and some
ganglion cells were also α-synuclein-immunoreactive. A simi-
lar α-synuclein distribution pattern was found in the rabbit
(Figure 3D), an animal with both crepuscular and nocturnal
vision capabilities. In the cone-dominant retina of the squirrel
(Figure 3E), a diurnal-vision mammal, a strong α-synuclein
labeling was detected in photoreceptor OS, and a cytoplasmic
staining was apparent in the somata of several cell types lying
in the INL, including bipolar, amacrine and likely also hori-
zontal cells. α-Synuclein expression was prominent in the IPL
of this species, with a band of lower immunoreactivity seen in
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Figure 3. α-Synuclein immunoreactivity pattern in the retina of mammalian vertebrates.  Shown are retinal sections immunolabeled for α-
synuclein from (A) mouse, (B) rat, (C) cat, (D) rabbit, (E) squirrel, (F) cow, (G) pig, (H) monkey, and (I) human. The following abbreviations
were used: outer nuclear layer (ONL), ganglion cell layer (GCL), inner nuclear layer (INL), outer plexiform layer (OPL), inner plexiform
layer (IPL), and outer segments (OS). Each bars equals 40 µm.
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stratum S3, along with some immunolabeled ganglion cells.
The cow (Figure 3F) and pig (Figure 3G), exhibited signifi-
cant α-synuclein levels in photoreceptors only in their OS,
together with a weak staining in the OPL. α-Synuclein
immunostaining was also found in amacrine and bipolar cell
bodies in the INL and in processes spreading throughout the
IPL. Similar patterns of distribution of this protein were ob-
served in the retina of primates, such as the macaque (Figure
3H) and the human (Figure 3I).
To further address the intracellular distribution of α-
synuclein in vertebrate photoreceptors, we performed double
and triple immunostainings with antibodies to α-synuclein and
to specific molecular markers for cones and rods. Micrographs
of the light-adapted carp retina, where all cones appear short-
ened in length and rods elongated, are presented in Figure 4A,
showing the presence of this protein in the cone OS. Figure
2A, illustrates α-synuclein immunoreactivity in the rod OS of
the fish (arrows). A double immunolabeling of the turtle retina
for α-synuclein and cone transducin is shown in Figure 4B,
together with staining for α-synuclein alone in Figure 4C. As
seen, colocalization between these two markers was detected
in this reptile in both the OS and pedicles of cones. In the
chicken, double staining for α-synuclein and rhodopsin re-
vealed the presence of α-synuclein in the OS of rods (Figure
4D, arrowhead), whereas triple labeling for α-synuclein,
rhodopsin, and calbindin, illustrated in Figure 4E, showed
colocalization of α-synuclein and calbindin in the cone OS
(arrowheads) and axon terminals (arrows). Expression of α-
synuclein in the rod OS of the mouse, scotopic retina is shown
in Figure 4F (red), and double labeling with calbindin showed
colocalization between these two markers in the OS of cones
(magenta). Colabeling for α-synuclein and transducin was also
found in the cone OS of the rat retina (Figure 4G, magenta).
To determine whether blue cones in particular expressed α-
synuclein, coimmunolabeling was carried out with antibodies
to S-cone opsin (JH455). Colocalization between these two
proteins was observed in the OS of blue cones (compare Fig-
ure 4H,I). Double staining for α-synuclein and rhodopsin also
revealed that rod photoreceptors of the rat exhibited α-
synuclein in their OS (Figure 4J). In the cat, triple
immunostaining for α-synuclein, calbindin and rhodopsin dis-
closed an intense colocalization of α-synuclein with rhodop-
sin in the OS of rods, as shown in Figure 4K (yellow), and
with calbindin in the OS (arrowhead) and pedicles (arrows) of
cones. As for the cone-dominant retina of the squirrel, α-
synuclein colabeling with transducin was found in the OS of
cones (Figure 4L, yellow), and with rhodopsin in the OS of
rods (Figure 4M, yellow). α-Synuclein was contained as well
in the axon terminals of photoreceptors in this species (Figure
4L-N). The presence of this protein in cone OS of the bovine
retina is shown by its colabeling at this location with transducin
(Figure 4O, arrowhead). For primates, we used recoverin as a
simultaneous marker for cones and rods. As illustrated in the
macaque retina (compare Figure 4P,Q), α-synuclein located
to the OS of both photoreceptor cell types (Figure 4P, ma-
genta). A double labeling with cone transducin revealed its
additional presence in cone pedicles (Figure 4R, arrows) and
rod spherules (Figure 4S, arrowheads), the latter being
transducin-negative. A pattern of α-synuclein distribution simi-
lar to that observed in the monkey was found in human photo-
receptors upon triple immunostaining for α-synuclein,
calbindin and rhodopsin (Figure 4T).
With the aim of assessing the particular cell subtypes ex-
pressing α-synuclein among the neurons making synapses in
the two retinal plexiform layers, we performed double and
triple immunolabeling experiments for α-synuclein and spe-
cific markers for bipolar, horizontal, and amacrine cells. As
shown for the mouse (Figure 5A) and rat (Figure 5B) retinas,
the distribution of the α-synuclein protein in the IPL was ho-
mogeneous, i.e. without noticeable stratification along this
layer. Double staining with antibodies to α-synuclein and to
protein kinase C (PKC) α isoform, a marker for rod bipolar
cells, showed that α-synuclein was present in the axon termi-
nals of this cell type in the IPL (Figure 5A,B, yellow), with
additional weak immunoreactivity observed in their dendritic
terminals in the OPL. Immunolabeling for PKC in the squir-
rel retina has been reported in rod bipolar cells of the B4 sub-
type, whose axons ramify in the IPL stratum S5, and in cone
bipolars identified as belonging to the B5 and B6 subtypes,
whose axon terminals locate to strata S3 and S4 [36]. Figure
5C shows colocalization of α-synuclein and PKC in bipolar
cells of the B4, B5, and B6 subtypes in this species. On the
other hand, anti-calbindin antibodies, which stain cone bipo-
lar cells in the squirrel retina, allowed the identification of
three cone bipolar subtypes according to their branching pat-
tern [36] which exhibited α-synuclein in their axon terminals:
the B2 subtype, whose dendrites stratify in stratum S2 of the
IPL, the B5 sybtype, branching at the IPL S4-S5 interphase,
and the B8 subtype, bistratifying at the S1-S2 and S4-S5 bor-
ders (Figure 5D). In some mammalian species horizontal cells
were also labeled with antibodies to α-synuclein (Figure 5A,
arrows). As shown, colocalization between calbindin and α-
synuclein was found in horizontal cells of the squirrel (Figure
5D, arrows) and the rat (Figure 5E, arrow). To determine
whether α-synuclein positive cells in the INL used either
GABA glycine, or both as neurotransmitters, we did triple
immunolabelings for these markers. Some GABAergic ama-
crine cells were found to exhibit α-synuclein immunoreactiv-
ity, as shown for the mouse (Figure 5F), rat (Figure 5G,H),
and rabbit (Figure 5I) retinas (closed arrowheads). In addi-
tion, colocalization between α-synuclein and glycine was ob-
served in amacrine cells of the squirrel (Figure 5C), rat (Fig-
ure 5H), and rabbit (Figure 5I) retinas (open arrowheads). Some
α-synuclein-positive amacrines were found to contain both
GABA and glycine as neurotransmitters (Figure 5F, white
cells). Finally, some glycinergic cone bipolar cells in these
species were detected as well to express α-synuclein (Figure
5C,F,H,I, arrows).
Synaptophysin is a membrane protein constituent of pr-
esynaptic vesicles in the CNS, including the retina [37], which
is present in photoreceptor axon endings in the OPL and in
bipolar and amacrine cell terminals in the IPL [38,39]. Double
labeling for α-synuclein and synaptophysin showed
colocalization in many, but not all, immunoreactive puncta in
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Figure 4. Expression of α-synuclein in photoreceptor cells.  Shown are immunolabeled views of (A) carp, (B, C) turtle, (D, E) chicken, (F)
mouse, (G-J) rat, (K) cat, (L-N) squirrel, (O) cow, (P-S) monkey, and (T) human photoreceptors. α-Synuclein immunostained red in all
panels. Single, double, or triple labelings for different photoreceptor markers are shown. Cone transducin (TD) stained green in panels B, L,
O, and R, and stained blue in panel G. Rhodopsin (RHO) stained green in panels D, E, J, K, M, and T, and S-cone opsin (JH455) stained green
in panel H. Calbindin (CB) stained blue in panels E, F, K, and T, as did recoverin (REC) in P. Arrowheads point to outer segments of rods
(panel D) and cones (panels E, K, O). Arrows mark cone pedicles (panels E, K, R), while arrowheads point to rod spherules (panel S). Each
bars equals 10 µm.
955the IPL of all the species studied, from birds to primates (Fig-
ure 6A-F, yellow). This pattern was attributed to the existence
of different bipolar and amacrine cell subtypes that contained
either or both proteins in their synaptic terminals. Figure 6I
illustrates the expected colocalization between α-synuclein and
synaptophysin in the OPL for the pig retina.
To determine whether α-synuclein was present in the den-
drites of ganglion cells, we performed double immunostaining
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Figure 5. Expression of α-synuclein in horizontal, bipolar, and amacrine cells.  Shown are immunolabeled sections of (A, F) mouse, (B, E, G,
H) rat, (C, D) squirrel, and (I) rabbit retinas. α-Synuclein immunostained red in all panels. Single, double, or triple labelings were carried out
for the indicated retinal neuronal markers. Protein kinase C (PKC) stained green in panels A and B and blue in C. Glycine (GLY) stained green
in panels C, F, H and I. Calbindin (CB) stained blue in panels D and E, as did GABA in panels F-I. Arrows point to horizontal cells in A, D
and E, and to glycinergic bipolar cells in panels C, F, H, and I. Open arrowheads point to glycinergic amacrines (panels C, H, I) and closed
arrowheads to GABAergic amacrines (panels F-I). Each bars equals 10 µm.
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Figure 6. Colocalization between α-synuclein and synaptophysin in the inner plexiform layer.  Shown are immunolabeled retina sections of
(A) chicken, (B) mouse, (C) squirrel, (D) cow, (E, G-I) pig, and (F) monkey. α-Synuclein immunostained red in all panels, synaptophysin
(SYP) stained green in panels A-F and I, and microtubule-associated protein-2 (MAP2) stained blue in panels H and I. Lack of colocalization
between α-synuclein and synaptophysin is evident in panel I. Each bar equals 10 µm.
957experiments for α-synuclein and MAP2, a specific marker for
this retinal neuronal type. Figure 6G shows the distribution of
α-synuclein in the IPL of the pig retina. Double labeling with
antibodies to α-synuclein showed the lack of a clear
colocalization of this protein with MAP2 (Figure 6H), indi-
cating that ganglion cells are not likely to express α-synuclein
in their dendrites in the pig retina. Further, no colocalization
was found between MAP2 and synaptophysin in the dendrites
of ganglion cells in the IPL (Figure 6I).
Given our finding of α-synuclein mRNA and protein in
the mammalian RPE (Figure 1), we analyzed α-synuclein sub-
cellular distribution in this retinal layer in vertebrates by im-
munohistochemical methods. A cytoplasmic labeling pattern
was found in RPE cells of vertebrates, especially in carp (Fig-
ure 2A), toad (Figure 2B), turtle (Figure 7A), squirrel (Figure
7C), and monkey (Figure 7D). α-Synuclein appeared excluded
from the nuclei of these cells, and a strong punctate immu-
noreactivity pattern was observed in the region of epithelial
cells close to the OS of cones and rods (Figure 7, arrowheads).
A double immunostaining for α-synuclein and rhodopsin re-
vealed a number of such structures colocalizing both proteins
in the human retina (Figure 7E, yellow). This was also the
case for α-synuclein and cone transducin in the squirrel retina
(Figure 7F, magenta), which, based on their size (0.7-1.4 µm),
could well constitute phagosomes containing OS disc mem-
branes being phagocytized by RPE cells.
DISCUSSION
 The synucleins constitute a family of structurally-related pro-
teins of widespread expression in the vertebrate neurons. Dys-
function of these proteins has been linked to the onset and
progression of neurodegenerative diseases [7,8,10,21,22,40].
Members of this family include α- and β-synucleins, which
locate at axon presynaptic terminals of the CNS, and γ-
synuclein, which is most abundant in neurons of the periph-
eral nervous system but is also present in the retina and optic
nerve. Although their precise functions remain not completely
understood, synucleins are throught to integrate presynaptic
signaling and membrane trafficking [7,9,15]. The pattern of
expression and distribution of α-synuclein in the retina has
not been previously characterized, and only its predominant
presence in the IPL of the mouse and human retinas has been
shown [41,42]. However, the particular retinal cell types ex-
hibiting α-synuclein in the mammalian retina are not known,
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Figure 7. Expression of α-synuclein in retinal epithelial cells.  Shown are immunolabeled retina sections of retinal pigment epithelium and
photoreceptor outer segment layers for (A) turtle, (B) Swiss mouse, (C, F) squirrel, (D) monkey, and (E) human retinas. α-Synuclein was
immunostained red in all panels, rhodopsin (RHO) stained green in panel E; and cone transducin (TD) stained blue in panel F. Arrowheads
point to phagosome-like structures in the apical region of retinal epithelial cells. Each bars equals 10 µm.
958and its distribution pattern in the retina of other vertebrates
has not been previously addressed.
In this work we showed expression of α-synuclein at the
mRNA and protein levels in the neural retina of mammals,
including rodent (rat and mouse), bovine, and primate (hu-
man and monkey) retinas. This protein exhibited an apparent
size of 19 kDa on immunoblots, despite its real 14.5 kDa
molecular mass, as previously reported [1,2,4,6,16,23]. This
variation, leaving aside possible postranslational modifications,
has been mainly attributed to low binding of SDS by its highly-
acidic C-terminus [6,43].
The retinal distribution profile of α-synuclein, as assessed
by immunohistochemistry, was consistent in all the species
studied, which was indicative of a similar role for this protein
across vertebrates. In this pattern, we have found a strong α-
synuclein immunolabeling in the OS of both cone and rod
photoreceptors, a location where α-synuclein has been previ-
ously not noticed [41,42]. Since roles have been proposed for
α-synuclein in the formation and recycling of synaptic vesicles,
as well as in the maintenance of synapse structure in the CNS
[7-10,15], and given that OS discs are formed within photore-
ceptors through the apposition and fusion of membrane
vesicles, an involvement of α-synuclein in the turnover of OS
discs and/or in maintenance of their structural integrity can be
postulated.
To date, the presence of α-synuclein in the OPL of the
mammalian retina has not been reported. However, we ob-
served a concentration of α-synuclein at photoreceptor axon
terminals of vertebrates, including both cone pedicles and rod
spherules. Additionally, we noted several subtypes of bipolar
and amacrine cells of retinas from both nocturnal and diurnal
animals that were found to express α-synuclein. This protein
was immunolocalized to the cell bodies and (predominantly)
to the axon terminals of both rod and cone bipolar cells, as
well as to the somata and dendrites of both glycinergic and
GABAergic amacrine cells, yielding an intense immunoreac-
tivity pattern along the IPL. Given that α-synuclein accumu-
lates at presynaptic nerve endings in the brain, where it likely
participates in the synaptic-vesicle cycle, including neurotrans-
mitter storage, release and reuptake [13,14,44-46], an equiva-
lent role of α-synuclein in synaptic function at both plexiform
layers of the vertebrate retina can thus be inferred.
Synaptophysin is a synaptic-vesicle transmembrane pro-
tein with an active involvement in the regulation of vesicular
exocytosis in the CNS. This protein has been immunolocalized
to presynaptic terminals at both the OPL and IPL in the reti-
nas of a wide range of vertebrate species [38,39,47-50], where
it is a constituent protein of synaptic vesicles [37,48,51]. We
found colocalization of α-synuclein with synaptophysin in
photoreceptor terminals in the OPL as well as in bipolar and
amacrine cell endings in the IPL, although no such
colocalization was observed in the dendrites of ganglion cells.
These results indicate that α-synuclein is present in presynap-
tic, but not postsynaptic, terminals of retinal neurons in both
plexiform layers, where it could be associated with synaptic
vesicles to modulate neurotransmission.
Expression of α-synuclein was not restricted to the neu-
ral retina, but this protein was also present at significant lev-
els in the RPE. Although γ-synuclein has been found in cul-
tured bovine RPE cells [52], α-synuclein has been reported to
be absent from the human RPE, iris, cornea and lens [41].
However, we have determined by immunohistochemistry that
α-synuclein expression in the RPE is not just a feature of mam-
mals, it extends to vertebrates in general. In addition to its
general cytoplasmic distribution, an accumulation of α-
synuclein was apparent in the form of a punctate pattern in the
apical region of RPE cells. The size of these aggregates and
the colocalization of α-synuclein in these particles with
rhodopsin or transducin, which are proteins contained in rod
and cone OS, respectively, strongly suggest that they consti-
tute phagosomes [53], i.e. vesicular structures arising from
the phagocytosis by retinal epithelial cells of discs shed from
the OS of photoreceptors. Therefore, α-synuclein detected in
these structures within RPE cells would derive from its pres-
ence in photoreceptor disc membranes, a possibility that should
be ascertained by electron microscopy analysis. However, our
findings of abundant α-synuclein mRNA levels in RPE tissue
along with α-synuclein protein distribution throughout the
cytoplasm indicate that retinal epithelial cells exhibit as well
the property of α-synuclein mRNA and protein synthesis. In
this context, it must be mentioned that α-synuclein expres-
sion has also been reported at low levels in organs other than
the brain [1,54], as well as in epithelial cells of the human
olfactory mucosa [55].
Taken together, our results allow us to postulate a func-
tion of α-synuclein in synaptic transmission through both rib-
bon-type and conventional synapses of the retina. Such an in-
volvement of this protein has been previously suggested at
the IPL level [41]. Given its wide retinal distribution and po-
tentially relevant role in retinal function, it remains a formal
possibility that, inasmuch as certain mutations in the SNCA
gene are known to be associated with neurological disorders
in the brain, unsought α-synuclein genetic alterations could
be causative of retinitis pigmentosa and other retinal
neurodegenerative diseases. In this context, retinal degenera-
tion has been found in parkinsonian Drosophila transgenic
lines expressing wild-type or mutant variants of human α-
synuclein in the eye [56]. This issue deserves further study.
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